ARTICLES BY THIS AUTHOR
- 11/29/2021
Panel tackles pharmacies becoming healthcare destinations on 2nd day of DSN Industry Issues Summit
The second panel of DSN’s annual Industry Issues Summit focused on how pharmacies are becoming healthcare destinations. - 11/29/2021
Par debuts generic Miacalcin
Calcitonin salmon injection is indicated for the early treatment of hypercalcemic emergencies, along with other appropriate agents, when a rapid decrease in serum calcium is required. - 11/29/2021
Seqirus receives FDA nod for new Audenz presentation
The FDA approved Seqirus’ multidose vial presentation for Audenz to help protect individuals aged six months old and older against influenza A(H5N1) in the event of a pandemic. - 11/29/2021
CVS Pharmacy takes Spoken Rx labels nationwide
Spoken Rx, designed for people with visual impairments or who cannot read standard print labels, uses technology that reads prescription information out loud. - 11/29/2021
Walgreens Boots Alliance attains remaining stake in McKesson’s GEHE, Alliance Healthcare ventures
Walgreens Boots Alliance will become the owner of the combined GEHE and Alliance Healthcare businesses in Germany. - 11/28/2021
BioTek reMEDys to provide Uplizna
Uplizna is used to treat adults with neuromyelitis optica spectrum disorder who are anti-aquaporin-4 antibody positive. - 11/28/2021
Mayne Pharma names new board member
Carolyn Myers, who has experience in business development, sales, marketing, strategy and portfolio management, has led the launch of more than 20 brand products. - 11/28/2021
CVS Health pledges $7.7M investment in affordable housing for Tampa, Fla.
CVS Health will invest $7.7 million with Raymond James Tax Credit Funds to build a 61 unit multifamily apartment home development called Uptown Sky in Tampa, Fla. - 11/28/2021
Industry Issues Summit panel weighs in on how focusing on patients can improve outcomes
The first panel of DSN’s annual Industry Issues Summit highlighted how a laser focus on patients can drive improved outcomes. - 11/28/2021
Walmart’s CFO to depart
Brett Biggs will remain in the CFO role until a successor is named in 2022. He will support the role transition by remaining an associate until Jan. 31, 2023.